S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
ASX:IDX

Integral Diagnostics Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume240,828 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield2.90%
BetaN/A

Receive IDX News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.


About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company provides its services through 64 radiology clinics, including 20 hospital sites. Integral Diagnostics Limited was incorporated in 2008 and is headquartered in Melbourne, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
$350.70 million
Book Value
A$1.28 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.05 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Integral Diagnostics (ASX:IDX) Frequently Asked Questions

What stocks does MarketBeat like better than Integral Diagnostics?

Wall Street analysts have given Integral Diagnostics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Integral Diagnostics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics?

Integral Diagnostics announced a Final dividend on Monday, August 30th. Shareholders of record on Tuesday, October 5th will be paid a dividend of 0.07 per share on Tuesday, October 5th. This represents a yield of 1.47%. The ex-dividend date is Wednesday, September 1st. This is a boost from Integral Diagnostics's previous Final dividend of A$0.04.
View Integral Diagnostics' dividend history
.

Is Integral Diagnostics a good dividend stock?

Integral Diagnostics pays an annual dividend of A$0.14 per share and currently has a dividend yield of 2.90%. The dividend payout ratio of Integral Diagnostics is 89.74%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Integral Diagnostics' dividend history.

Who are Integral Diagnostics' key executives?

Integral Diagnostics' management team includes the following people:
  • Dr. Ian Kadish M.B.A., MBBCh, MBA, CEO, MD & Director (Age 58, Pay $804.61k)
  • Ms. Anne Lockwood, CFO & Chief Commercial Officer
  • Dr. Jacqueline Milne MBBS, Exec. Director
  • Mr. Paul McCrow, Chief Operating Officer
  • Mr. Julian Gully, Chief Information Officer
  • Ms. Mica Duncalfe, Chief People Officer
  • Dr. Nazar Bokani, Exec. Director
  • Ms. Kirsty Lally B.Com., C.A., Company Sec.

What other stocks do shareholders of Integral Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integral Diagnostics investors own include Gevo (GEVO), Fluidigm (FLDM), EML Payments (EML), electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Chimerix (CMRX), Capricor Therapeutics (CAPR), Bathurst Resources (BRL) and Athersys (ATHX).

What is Integral Diagnostics' stock symbol?

Integral Diagnostics trades on the ASX under the ticker symbol "IDX."

How much money does Integral Diagnostics make?

Integral Diagnostics has a market capitalization of $0.00 and generates $350.70 million in revenue each year.

How many employees does Integral Diagnostics have?

Integral Diagnostics employs 1,149 workers across the globe.

What is Integral Diagnostics' official website?

The official website for Integral Diagnostics is www.integraldiagnostics.com.au.

How can I contact Integral Diagnostics?

The company can be reached via phone at 61 3 5339 0704.


This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.